Brief: Crossject gets authorization to conduct study on bioequivalence of Zeneo Midazolam

Crossject SA

06/03/2017 07:15

March 6 (Reuters) - Crossject SA  ALCJ.PA : 
    * Gets authorization to conduct study on bioequivalence of 
Zeneo Midazolam 
 
Source text for Eikon:  urn:newsml:reuters.com:*:nGNE9SM3R3 
Further company coverage:  ALCJ.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))